Patient Travel Experiences for Methadone Dosing Visits

In this mixed-methods qualitative study, requiring regular visits for in-person observed methadone dosing presented significant structural barriers that affect patients’ treatment experience, adherence, and lives. Increasing the flexibility and accessibility of methadone treatment—through policies and novel care practices that actively seek to minimize burden of travel to the OTP and destigmatize care—is essential to enhance care quality and equity.

Corresponding Author: Elizabeth J. Austin, PhD, MPH, Division of General Internal Medicine, School of Medicine, University of Washington, Box 351621, Seattle, WA 98105 (austie@uw.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.